Mulmit

BIO-PATH HOLDINGS, INC.BIO-PATH HOLDINGS, INC.

BPTH OTC

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2018-12-310-8,590,000-8,583,000
2017-12-3137,000-8,966,000-7,023,000
2016-12-3113,000-8,475,000-6,750,000
2015-12-310-5,485,000-5,467,000
2014-12-310-4,542,000-4,519,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2024-07-30Sherwood Aline2,000
2024-07-30Aubert Paul2,000
2024-07-30Cleaver Heath2,000
2024-07-30MORRIS DOUGLAS P3,537
2024-07-30Nielsen Peter HenryPresident, CEO & CFO25,000
2023-05-02Cleaver Heath10,000
2023-05-02Aubert Paul10,000
2023-05-02Sherwood Aline10,000
2023-05-02MORRIS DOUGLAS P13,000
2023-05-02Nielsen Peter HenryPresident, CEO & CFO105,000
2022-03-31Sherwood Aline10,000
2022-03-28Aubert Paul10,000

8-K events

FiledItems
2026-07-16Unregistered sales of equity securities · Amendments to charter or bylaws · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-26Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-20Amendments to charter or bylaws · Other events · Financial statements and exhibits
2026-02-24Change in control · Amendments to charter or bylaws · Regulation FD disclosure · Other events
2025-11-14Officer or director change · Other events
2025-10-29Officer or director change
2025-08-13Change in certifying accountant · Financial statements and exhibits
2025-06-24Officer or director change · Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.